Advanced

Outcome after percutaneous coronary intervention for different indications : Long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Fokkema, Marieke L.; James, Stefan K.; Albertsson, Per LU ; Aasa, Mikael; Åkerblom, Axel; Calais, Fredrik; Eriksson, Peter; Jensen, Jens; Schersten, Fredrik LU and De Smet, Bart J., et al. (2016) In EuroIntervention 12(3). p.303-311
Abstract

Aims: The aim of this study was to evaluate clinical outcome for different indications for PCI in an unselected, nationwide PCI population at short-and long-term follow-up. Methods and results: We evaluated clinical outcome up to six years after PCI in all patients undergoing a PCI procedure for different indications in Sweden between 2006 and 2010. A total of 70,479 patients were treated for stable coronary artery disease (CAD) (21.0%), unstable angina (11.0%), non-ST-elevation myocardial infarction (NSTEMI) (36.6%) and ST-elevation myocardial infarction (STEMI) (31.4%). Mortality was higher in STEMI patients at one year after PCI (9.6%) compared to NSTEMI (4.7%), unstable angina (2.2%) and stable CAD (2.0%). At one year after PCI... (More)

Aims: The aim of this study was to evaluate clinical outcome for different indications for PCI in an unselected, nationwide PCI population at short-and long-term follow-up. Methods and results: We evaluated clinical outcome up to six years after PCI in all patients undergoing a PCI procedure for different indications in Sweden between 2006 and 2010. A total of 70,479 patients were treated for stable coronary artery disease (CAD) (21.0%), unstable angina (11.0%), non-ST-elevation myocardial infarction (NSTEMI) (36.6%) and ST-elevation myocardial infarction (STEMI) (31.4%). Mortality was higher in STEMI patients at one year after PCI (9.6%) compared to NSTEMI (4.7%), unstable angina (2.2%) and stable CAD (2.0%). At one year after PCI until the end of follow-up, the adjusted mortality risk (one to six years after PCI) and the risk of myocardial infarction were comparable between NSTEMI and STEMI patients and lower in patients with unstable angina and stable CAD. The adjusted risk of stent thrombosis and heart failure was highest in STEMI patients. Conclusions: The risk of short-term mortality, heart failure and stent thrombosis is highest for STEMI patients after PCI. Therapies to reduce stent thrombosis and heart failure appear to be most important in decreasing mortality in patients with STEMI or NSTEMI undergoing PCI.

(Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Coronary artery disease, Indications, Myocardial infarction, Percutaneous coronary intervention, Prognosis
in
EuroIntervention
volume
12
issue
3
pages
9 pages
publisher
Société Europa Edition
external identifiers
  • scopus:84975806577
  • wos:000380083100005
ISSN
1774-024X
DOI
10.4244/EIJY15M10_07
language
English
LU publication?
yes
id
225cdeed-b7d7-41bb-994a-24e4a6f5b346
date added to LUP
2016-07-25 11:37:17
date last changed
2017-10-22 05:17:47
@article{225cdeed-b7d7-41bb-994a-24e4a6f5b346,
  abstract     = {<p>Aims: The aim of this study was to evaluate clinical outcome for different indications for PCI in an unselected, nationwide PCI population at short-and long-term follow-up. Methods and results: We evaluated clinical outcome up to six years after PCI in all patients undergoing a PCI procedure for different indications in Sweden between 2006 and 2010. A total of 70,479 patients were treated for stable coronary artery disease (CAD) (21.0%), unstable angina (11.0%), non-ST-elevation myocardial infarction (NSTEMI) (36.6%) and ST-elevation myocardial infarction (STEMI) (31.4%). Mortality was higher in STEMI patients at one year after PCI (9.6%) compared to NSTEMI (4.7%), unstable angina (2.2%) and stable CAD (2.0%). At one year after PCI until the end of follow-up, the adjusted mortality risk (one to six years after PCI) and the risk of myocardial infarction were comparable between NSTEMI and STEMI patients and lower in patients with unstable angina and stable CAD. The adjusted risk of stent thrombosis and heart failure was highest in STEMI patients. Conclusions: The risk of short-term mortality, heart failure and stent thrombosis is highest for STEMI patients after PCI. Therapies to reduce stent thrombosis and heart failure appear to be most important in decreasing mortality in patients with STEMI or NSTEMI undergoing PCI.</p>},
  author       = {Fokkema, Marieke L. and James, Stefan K. and Albertsson, Per and Aasa, Mikael and Åkerblom, Axel and Calais, Fredrik and Eriksson, Peter and Jensen, Jens and Schersten, Fredrik and De Smet, Bart J. and Sjögren, Iwar and Tornvall, Per and Lagerqvist, Bo},
  issn         = {1774-024X},
  keyword      = {Coronary artery disease,Indications,Myocardial infarction,Percutaneous coronary intervention,Prognosis},
  language     = {eng},
  month        = {06},
  number       = {3},
  pages        = {303--311},
  publisher    = {Société Europa Edition},
  series       = {EuroIntervention},
  title        = {Outcome after percutaneous coronary intervention for different indications : Long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)},
  url          = {http://dx.doi.org/10.4244/EIJY15M10_07},
  volume       = {12},
  year         = {2016},
}